Cancer marker tests, also called tumour marker tests, measure substances in the blood that can rise when certain cancers are present. Many advanced health checkup packages include a few of them. They’re useful tools in the right hands, but they are not cancer detection tests for healthy people, and knowing the difference protects you from both false reassurance and unnecessary anxiety.
This guide explains what the common markers are, which ones appear in checkup packages, what a raised result actually means, and when a doctor would genuinely order one.
What Is a Tumour Marker?
A tumour marker is a substance, usually a protein, produced either by cancer cells or by the body in response to cancer. Some are measured in blood, others in tissue after a biopsy. The ones in health checkup packages are blood tests.
The important nuance: most tumour markers are also produced in non-cancerous conditions. Inflammation, infection, benign growths, liver disease, smoking and even menstruation can raise them. That’s why a raised marker on its own doesn’t mean cancer, and a normal marker doesn’t rule it out.
Common Cancer Markers Found in Checkup Packages
PSA (Prostate-Specific Antigen)
Used in the evaluation of prostate health in men. Levels can rise with prostate cancer, but also with benign prostate enlargement, infection, recent ejaculation or a recent catheter or examination. PSA screening is a shared decision between a man and his doctor, typically discussed from around age 50, or earlier with a family history.
CA-125
Associated with ovarian cancer. It also rises in endometriosis, fibroids, pelvic infection, liver disease, pregnancy and during menstruation. It’s used mainly to evaluate a known ovarian mass or to monitor treatment, not to screen healthy women.
CEA (Carcinoembryonic Antigen)
Linked mostly to colorectal cancer. It’s used primarily to monitor patients already diagnosed and to detect recurrence. Smoking, liver disease and inflammatory bowel conditions can raise it too.
AFP (Alpha-Fetoprotein)
Associated with liver cancer and certain testicular and ovarian tumours. It’s most useful in people with known chronic liver disease, and in pregnancy it’s interpreted in a completely different context.
CA 19-9
Linked to pancreatic and biliary cancers. It also rises with gallstones, bile duct blockage, pancreatitis and liver disease. It is used to support diagnosis and monitor treatment, not to screen.
CA 15-3
Associated with breast cancer, used mainly to monitor treatment and detect recurrence in diagnosed patients.
Beta-hCG
Raised in certain testicular and ovarian germ cell tumours, and of course in pregnancy.
Thyroglobulin and Calcitonin
Used for follow-up in specific thyroid cancers, not general screening.
What Health Checkup Packages Typically Include
Packages vary widely, but the pattern is usually:
| Package type | Cancer markers usually included |
|---|---|
| Basic full-body checkup | None |
| Comprehensive / advanced checkup | Often PSA for men; sometimes CA-125 for women |
| Dedicated cancer marker panel | A combination of markers plus supporting tests, sex-specific |
| Doctor-directed testing | The specific markers relevant to your history or symptoms |
What a Dedicated Male Cancer Marker Panel Usually Contains
A typical male panel combines a handful of markers with supporting tests:
- Complete blood count (CBC), around 24 parameters, covering haemoglobin and white cell and platelet counts
- PSA (total), related to prostate health
- CEA, associated with colorectal and some other cancers
- AFP, associated with liver and certain germ cell tumours
- CA 19-9, associated with pancreatic and biliary cancers
- NSE (neuron specific enolase) with beta-hCG, associated with certain neuroendocrine and germ cell tumours
- Thyroglobulin, used in follow-up of specific thyroid cancers
- LDH, a general marker of cell turnover that rises in many conditions
- hs-CRP, a marker of inflammation, not of cancer
What a Dedicated Female Cancer Marker Panel Usually Contains
A typical female panel keeps the CBC, CEA, AFP, NSE with beta-hCG, thyroglobulin, LDH and hs-CRP, drops PSA, and adds:
- CA-125, associated with ovarian cancer
- CA 15-3, associated with breast cancer
- Progesterone and estradiol (E2), reproductive hormones included for context on cycle and menopausal status; these are not cancer markers
These panels usually need no fasting, and reports take longer than routine blood tests because several markers are specialised assays. Note that progesterone and estradiol are hormone tests rather than cancer markers, and hs-CRP and LDH are general markers that rise in many conditions, so a panel’s test count says little about how much cancer-related information it gives you.
Always read the exact parameter list rather than a headline count of tests, and ask which markers are included and why. A marker panel is a snapshot of a set of blood proteins; it is not a substitute for the age-appropriate screening tests covered in the next article.
What a Raised Marker Actually Means
The single most important thing to understand: tumour markers are not screening tests for people without symptoms.
A 2025 systematic review of 38 studies examining CA-125, CA 19-9, CEA, AFP and CA 15-3 in people without symptoms found that the positive predictive value was consistently low in the general population. False positives commonly led to further imaging, invasive procedures and surgery, with complication rates reaching up to 15% in some studies, and no mortality benefit was shown in large randomised trials. Clinical guidance groups across several countries advise against ordering these markers for asymptomatic people.
Put plainly, in a healthy population:
- A raised marker is far more often something harmless than cancer.
- A normal marker can still coexist with cancer, since many early cancers don’t raise markers at all.
- A false positive has real costs: anxiety, repeat tests, scans, and sometimes an invasive procedure you didn’t need.
When Tumour Markers Are Genuinely Useful
- Monitoring a diagnosed cancer: tracking response to treatment and detecting recurrence. This is their main established role.
- Evaluating symptoms or a known finding: for instance CA-125 when an ovarian mass has been found on ultrasound.
- High-risk surveillance: for example AFP with ultrasound in people with chronic hepatitis B or cirrhosis, done under specialist guidance.
- Prostate health discussion: PSA, as a shared decision between a man and his doctor.
The common thread is that a doctor orders the specific marker for a specific reason.
What to Do If Your Result Is Abnormal
- Don’t panic and don’t search the number in isolation. Most raised markers in healthy people aren’t cancer.
- See a doctor with your full report, not just the one abnormal line.
- Expect a repeat test. Markers fluctuate, and the trend matters more than a single value.
- Expect context to be gathered: symptoms, family history, examination, and imaging if indicated.
- Follow the doctor’s plan rather than requesting more markers, which usually adds noise rather than clarity.
A Better Approach to Cancer Risk
Instead of buying the widest marker panel, the more effective route is the screening that’s actually proven to reduce cancer deaths, matched to your age, sex and risk profile, alongside prevention: stopping tobacco in all forms, limiting alcohol, maintaining a healthy weight, staying active, and HPV and hepatitis B vaccination. Blog D2 covers which screening tests are recommended and when.
Frequently Asked Questions
1. Which health checkup packages in Pune include cancer marker tests?
Basic full-body checkups usually include no cancer markers. Comprehensive packages often add PSA for men and sometimes CA-125 for women, and dedicated cancer marker panels include a wider set: typically a complete blood count with CEA, AFP, NSE with beta-hCG, thyroglobulin, LDH and hs-CRP, plus PSA and CA 19-9 for men or CA-125 and CA 15-3 for women. Check the exact parameter list before booking, and ask a doctor which markers apply to you.
2. What is a cancer marker test?
A cancer marker or tumour marker test measures a substance in the blood that can rise when certain cancers are present. Common markers include PSA, CA-125, CEA, AFP, CA 19-9 and CA 15-3. These substances also rise in many non-cancerous conditions.
3. Can a blood test detect cancer early?
No single blood test reliably detects cancer early in people without symptoms. Tumour markers have low positive predictive value in the general population, and guideline bodies advise against using them as screening tests. Proven screening methods vary by cancer type, such as HPV testing for cervical cancer or mammography for breast cancer.
4. Does a high tumour marker mean I have cancer?
Not usually. Inflammation, infection, benign growths, liver disease, smoking, pregnancy and menstruation can all raise tumour markers. A raised result needs a doctor’s assessment and usually a repeat test, not immediate alarm.
Can I have cancer with normal tumour markers?
Yes. Many cancers, particularly in early stages, don’t raise blood markers at all. A normal result should never be taken as proof that cancer is absent, especially if you have symptoms that persist.
6. What is the difference between male and female cancer marker packages?
Male panels include PSA for prostate health and usually CA 19-9. Female panels replace these with CA-125 for ovarian health and CA 15-3 for breast health, and often add reproductive hormones such as progesterone and estradiol. Both share a complete blood count, CEA, AFP, NSE with beta-hCG, thyroglobulin, LDH and hs-CRP.
7. Should healthy people get a cancer marker panel?
Most guideline bodies advise against routine tumour marker testing in people without symptoms or known risk factors, because false positives lead to unnecessary scans, procedures and anxiety without evidence of benefit. Discuss with a doctor whether any marker is appropriate for you.
8. When are tumour marker tests genuinely useful?
They’re most useful for monitoring a diagnosed cancer during and after treatment, for evaluating specific symptoms or findings such as an ovarian mass, and for surveillance in defined high-risk groups, such as AFP with ultrasound in people with chronic liver disease.
9. Do I need a doctor’s prescription for a cancer marker test?
Many labs allow direct booking without a prescription. These tests are still far more useful when a doctor decides which markers apply to you and interprets the result alongside your symptoms, history and examination. A consultation before testing usually prevents unnecessary tests and avoidable worry.
10. Where can I book a cancer marker test in Pune?
Tumour marker tests such as PSA, CA-125, CEA, AFP and CA 19-9 are available at diagnostic labs across Pune, including Fittr Labs in Kharadi, individually or as part of a wider panel. Speaking to a doctor first is the more useful step, so that you test what’s relevant rather than the longest available list.
Before booking any marker panel, talk to a doctor about what’s actually relevant for your age, symptoms and family history.
